跳至主要内容
临床试验/NCT01249053
NCT01249053Unknown不适用

Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma

China Medical University Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1

研究概览

简要总结

Optic atrophy type 1(OPA1) is a nuclear dynamin-related GTPase, targeted to the inner mitochondrial membrane, which plays a role in mitochondrial fusion. Mitochondria fusion is associated with process of apoptosis. . OPA1 plays an important role in the mitochondrial bioenergetics and mitochondrial networks. The changes in mitochondrial shape and mitochondrial bioenergetics may be cause of the disease. In this study, we investigate the expression of OPA1 in lung adenocarcinoma (LADC) cells and tissue.

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
25 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • We will collect paraffin blocked resected lung tissue samples from stage I~IIIa non-small cell lung cancer patients (age, 40~80 years old) who received lobectomy of the affected lung.

排除标准

  • History of uremia, other malignant disease, and liver cirrhosis
  • History of pneumonia and pulmonary tuberculosis
  • History of long period of medications.

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验